Mersana Therapeutics (MRSN) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free MRSN Stock Alerts $4.51 +0.02 (+0.45%) (As of 10:27 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Mersana Therapeutics Short Interest DataCurrent Short Volume8,730,000 sharesPrevious Short Volume7,140,000 sharesChange Vs. Previous Month+22.27%Dollar Volume Sold Short$44.00 millionShort Interest Ratio / Days to Cover3.8Last Record DateMarch 15, 2024Outstanding Shares121,300,000 sharesPercentage of Shares Shorted7.20%Today's Trading Volume125,563 sharesAverage Trading Volume2,341,023 sharesToday's Volume Vs. Average5% Short Selling Mersana Therapeutics ? Sign up to receive the latest short interest report for Mersana Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRSN Short Interest Over TimeMRSN Days to Cover Over TimeMRSN Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Mersana Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20248,730,000 shares $44.00 million +22.3%N/A3.8 $5.04 2/29/20247,140,000 shares $38.84 million +0.6%N/A3.4 $5.44 2/15/20247,100,000 shares $27.26 million +6.8%N/A3.6 $3.84 1/31/20246,650,000 shares $21.01 million -10.0%N/A3.5 $3.16 1/15/20247,390,000 shares $22.32 million -11.9%N/A3.6 $3.02 12/31/20238,390,000 shares $19.46 million -0.8%N/A4.1 $2.32 Get the Latest News and Ratings for MRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mersana Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/20238,460,000 shares $17.34 million -28.7%N/A4.3 $2.05 11/30/202311,870,000 shares $19.59 million -13.9%N/A5.4 $1.65 11/15/202313,790,000 shares $21.24 million +22.3%N/A6.6 $1.54 10/31/202311,280,000 shares $13.42 million +0.1%N/A5.2 $1.19 10/15/202311,270,000 shares $17.47 million +10.5%N/A1.7 $1.55 9/30/202310,200,000 shares $12.95 million -10.7%N/A1.6 $1.27 9/15/202311,420,000 shares $16.22 million +8.4%N/A1.8 $1.42 8/31/202310,540,000 shares $11.70 million -13.0%N/A1.4 $1.11 8/15/202312,120,000 shares $15.27 million -9.5%N/A1.7 $1.26 7/31/202313,390,000 shares $16.40 million +118.8%N/A1.8 $1.23 7/15/20236,120,000 shares $22.34 million -3.0%N/A1.9 $3.65 6/30/20236,310,000 shares $20.76 million +26.0%N/A2 $3.29 6/15/20235,010,000 shares $19.49 million -14.8%N/A1.7 $3.89 5/31/20235,880,000 shares $44.22 million -9.4%N/A3.1 $7.52 5/15/20236,490,000 shares $51.60 million -11.6%N/A3.6 $7.95 4/30/20237,340,000 shares $32.15 million +1.1%N/A4.3 $4.38 4/15/20237,260,000 shares $30.13 million -0.6%N/A5.8 $4.15 3/31/20237,300,000 shares $30.00 million +16.6%N/A5.6 $4.11 3/15/20236,260,000 shares $28.48 million -10.3%N/A4.8 $4.55 2/28/20236,980,000 shares $42.30 million +20.1%N/A5.9 $6.06 2/15/20235,810,000 shares $36.95 million +1.9%N/A5.1 $6.36 1/31/20235,700,000 shares $37.51 million +9.2%N/A5.2 $6.58 1/15/20235,220,000 shares $31.63 million +3.6%N/A4.8 $6.06 12/30/20225,040,000 shares $29.53 million +11.8%N/A4.8 $5.86 12/15/20224,510,000 shares $31.12 million -5.1%N/A4.4 $6.90 11/30/20224,750,000 shares $31.64 million +0.4%N/A4.7 $6.66 11/15/20224,730,000 shares $32.73 million -12.4%N/A4.5 $6.92 10/31/20225,400,000 shares $42.44 million -6.3%N/A4.9 $7.86 10/15/20225,760,000 shares $37.90 million +7.9%N/A4.2 $6.58 9/30/20225,340,000 shares $36.10 million +38.0%N/A3.9 $6.76 9/15/20223,870,000 shares $29.57 million +8.4%N/A2.7 $7.64 8/31/20223,570,000 shares $26.78 million +3.2%N/A2.4 $7.50 8/15/20223,460,000 shares $26.68 million -9.9%N/A2.4 $7.71 7/31/20223,840,000 shares $19.47 million -19.5%N/A2.6 $5.07Grab Your Free Bitcoin Today! (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here MRSN Short Interest - Frequently Asked Questions What is Mersana Therapeutics' current short interest? Short interest is the volume of Mersana Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 8,730,000 shares of MRSN short. Learn More on Mersana Therapeutics' current short interest. What is a good short interest ratio for Mersana Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRSN shares currently have a short interest ratio of 4.0. Learn More on Mersana Therapeutics's short interest ratio. Which institutional investors are shorting Mersana Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mersana Therapeutics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and FNY Investment Advisers LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Mersana Therapeutics' short interest increasing or decreasing? Mersana Therapeutics saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 8,730,000 shares, an increase of 22.3% from the previous total of 7,140,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mersana Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Mersana Therapeutics: Phibro Animal Health Co. (4.23%), IGM Biosciences, Inc. (22.87%), Biomea Fusion, Inc. (40.61%), Esperion Therapeutics, Inc. (10.48%), Lyell Immunopharma, Inc. (8.91%), Revance Therapeutics, Inc. (10.43%), Nkarta, Inc. (15.61%), Lexicon Pharmaceuticals, Inc. (8.72%), ALX Oncology Holdings Inc. (10.70%), Marinus Pharmaceuticals, Inc. (6.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Mersana Therapeutics stock? Short selling MRSN is an investing strategy that aims to generate trading profit from Mersana Therapeutics as its price is falling. MRSN shares are trading up $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mersana Therapeutics? A short squeeze for Mersana Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRSN, which in turn drives the price of the stock up even further. How often is Mersana Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRSN, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Phibro Animal Health Short Interest Data IGM Biosciences Short Interest Data Biomea Fusion Short Interest Data Esperion Therapeutics Short Interest Data Lyell Immunopharma Short Interest Data Revance Therapeutics Short Interest Data Nkarta Short Interest Data Lexicon Pharmaceuticals Short Interest Data ALX Oncology Short Interest Data Marinus Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRSN) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryUrgent: Protect Your Investments from a Chinese InvasionBehind the MarketsSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace